Infections in Inborn Errors of STATs
- PMID: 39599507
- PMCID: PMC11597637
- DOI: 10.3390/pathogens13110955
Infections in Inborn Errors of STATs
Abstract
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is highly conserved and essential for numerous biological functions triggered by extracellular signals, including cell proliferation, metabolism, immune response, and inflammation. Defects in STATs, either loss-of-function or gain-of-function defects, lead to a broad spectrum of clinical phenotypes in humans, including a wide range of infectious complications. The susceptibility to pathogens can stem from defects in immune cells within the hematopoietic compartment, impaired barrier functions of non-hematopoietic compartment, or a combination of both, depending on the specific STAT defect as well as the pathogen exposure history. Effective management involves antimicrobial prophylaxis tailored to the patient's infection risk and improving disease control with targeted therapies and/or hematopoietic cell transplantation.
Keywords: STAT; antimicrobials; hematopoietic cell transplantation; pathogen.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity.J Allergy Clin Immunol. 2025 Feb;155(2):357-367. doi: 10.1016/j.jaci.2024.09.020. Epub 2024 Oct 4. J Allergy Clin Immunol. 2025. PMID: 39369964 Review.
-
JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.J Transl Med. 2012 Jun 7;10:116. doi: 10.1186/1479-5876-10-116. J Transl Med. 2012. PMID: 22676255 Free PMC article.
-
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices.Immunol Rev. 2024 Mar;322(1):311-328. doi: 10.1111/imr.13312. Epub 2024 Feb 2. Immunol Rev. 2024. PMID: 38306168 Review.
-
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.Drug Resist Updat. 2010 Jun;13(3):67-78. doi: 10.1016/j.drup.2010.04.001. Epub 2010 May 14. Drug Resist Updat. 2010. PMID: 20471303 Review.
-
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?J Cell Mol Med. 2022 Apr;26(7):1865-1875. doi: 10.1111/jcmm.17168. Epub 2022 Mar 3. J Cell Mol Med. 2022. PMID: 35238133 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources